Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
andrea.tubaro@uniroma1.it
Andrea Tubaro
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
andrea.tubaro@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Non-invasive ultrasound measurements in male patients with LUTS and benign prostatic obstruction. Implication for diagnosis and treatment
MINERVA UROLOGICA E NEFROLOGICA
2017
Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: a clinical algorithm from an Italian consensus statement
NEUROUROLOGY AND URODYNAMICS
2017
Metabolic Syndrome Does Not Increase the Risk of Ejaculatory Dysfunction in Patients With Lower Urinary Tract Symptoms and Benign Prostatic Enlargement. An Italian Single-center Cohort Study
UROLOGY
2017
Young academic urologist benign prostatic obstruction nomogram predicts clinical outcome in patients treated with transurethral resection of prostate. an Italian cohort study
MINERVA UROLOGICA E NEFROLOGICA
2017
Benign prostatic enlargement can be influenced by metabolic profile. results of a multicenter prospective study
BMC UROLOGY
2017
PD61-11 THE NEW EPSTEIN GLEASON SCORE CLASSIFICATION SIGNIFICANTLY REDUCES UPGRADING IN PROSTATE CANCER PATIENTS
THE JOURNAL OF UROLOGY
2017
Basic methods for the assessment of health-related quality of life in uro-oncological patients
MINERVA UROLOGICA E NEFROLOGICA
2017
Meta-analysis of metabolic syndrome and prostate cancer
PROSTATE CANCER AND PROSTATIC DISEASES
2017
The influence of the medical treatment of LUTS on benign prostatic hyperplasia surgery: Do we operate too late?
MINERVA UROLOGICA E NEFROLOGICA
2017
Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
CURRENT UROLOGY REPORTS
2017
Is early benign prostatic hyperplasia (BPH) treatment worthwhile?
UROLOGIA
2017
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: A critical analysis of five phase III studies
THERAPEUTIC ADVANCES IN UROLOGY
2017
Can a patient reported outcome be adequate without assessing quality of life in lower urinary tract dysfunction?
NEUROUROLOGY AND URODYNAMICS
2017
The impact of nocturnal polyuria in older people with nocturnal LUTS
MINERVA UROLOGICA E NEFROLOGICA
2017
Quality of life after prostate cancer diagnosis: data from the pros-IT CNR
EUROPEAN UROLOGY FOCUS
2017
Physical activity as a risk factor for prostate cancer diagnosis. a prospective biopsy cohort analysis
BJU INTERNATIONAL
2016
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer. a single biopsy cohort analysis
PROSTATE CANCER AND PROSTATIC DISEASES
2016
541 Metabolic abnormalities linked to an increased cardiovascular risk are associated with higher storage lower urinary tract symptoms
EUROPEAN UROLOGY. SUPPLEMENTS
2016
Trends in the use of partial nephrectomy for cT1 renal tumors. analysis of a 10-yr european multicenter dataset
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2016
Real-life clinical practice of onabotulinum toxin A intravesical injections for overactive bladder wet: an Italian consensus statement
WORLD JOURNAL OF UROLOGY
2016
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
Effetti della combinazione sequenziale di Mitomicina e Bacillo di Calmette e Guérin rispetto alla monoterapia con Bacillo di Calmette e Guérin nel trattamento del carcinoma uroteliale non muscolo invasivo di alto grado con alto rischio di progressione
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma